Tuesday, February 15, 2022
9:30 AM–11:00 AM EST | 2:30 PM–4:00 PM GMT | 5:30 PM–7:00 PM EAT
Click here for your local time zone
The private sector holds great potential to reduce unmet need for family planning, and many countries are poised to adopt a total market approach for increasing contraceptive access through private pharmacies and drug shops. Policies supporting scale-up of family planning service provision and expanding method options such as DMPA-SC self-injection, must be prioritized in these entities.
The PATH-JSI DMPA-SC Access Collaborative and our partners have gained valuable insights with relevance to private sector engagement on self-injection. Through this virtual discussion, we aim to highlight lessons learnt, challenges, recommendations, and considerations for policies supporting private sector engagement in
self-injection in different country contexts. Specific topics to be discussed include:
-
Financing and commodity production ecosystems
-
Procurement and supply chains
-
Service delivery and programming
-
Data reporting and monitoring
-
Advocacy
-
Demand generation
This discussion will be moderated by Allen Namagembe, Deputy Project Director, Uganda DMPA-SC Access Collaborative, PATH.
Panelists:
-
Dr. Kayode Afolabi, Director and Head, Reproductive Health Division, Federal Ministry of Health, Nigeria
-
Dr. Daniella Munene, Chief Executive Officer, Pharmaceutical Society of Kenya
-
Mr. Kennedy Saini, President, Pharmaceutical Society of Zambia
-
Dr. Hortense Randrianaivo, President, Association of Pharmacists of Madagascar
-
Mr. Célestin Compaore, Regional Project Director, DMPA-SC, Jhpiego, Burkina Faso
This event will be held in English and French with simultaneous interpretation provided. We look forward to having you join us virtually. Please register in advance below.
|